By Alan D. Simon M.D., Mark K. Warshofsky M.D. (auth.), LeRoy E. Rabbani M.D. (eds.)
Restenosis, the proliferation of delicate muscle cells (SMC) that line blood vessels, frequently follows angioplasty. regardless of advances in cardiology, restenosis maintains to impact as much as forty% of the over 500,000 sufferers who suffer angioplasty every year.
Applications of Antisense remedies to Restenosis is the 1st quantity to deal with the possibility of utilizing antisense treatments to inhibit the restenosis that happens after percutaneous transluminal angioplasty and coronary stenting. The paintings seriously examines the appliance of assorted antisense cures for inhibiting restenosis.
Read or Download Applications of Antisense Therapies to Restenosis PDF
Similar nonfiction_10 books
1. 1 what's Selectivity? function, and crop protecting agent for the A biologically-active substance is expounded to be moment, yet there isn't any primary distinction selective if it strongly impacts sure cells with of precept of their mode of motion. out inflicting any swap in others, even if the Drug treatment has , essentially different types of cells are shut neighbours.
This quantity, the 6th within the IBAGS sequence, summarizes significant contributions in scientific and simple study at the basal ganglia. The 6th assembly of the Society was once hung on Cape Cod, within the nation of Massachusetts, united states, in October, 1998. Altogether sixteen nations have been represented by means of 227 members. This quantity comprises papers contributed via individuals.
Extra resources for Applications of Antisense Therapies to Restenosis
100. 101. 102. 103. 104. 105. 106. 107. 108. 109. 110. Ill. 112. 113. 114. 115. 116. Shuman MA Thrombin-cellular interactions. Ann NY Acad Sci, 1986;485:228. 'II. Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Inve&t, 1992;90:1614. Vu TK. Hung DT, Wheaton VI, and Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell, 1991;64:1057. 'II. Involvement ofNF-kappa B activation in thrombin-induced human vascular smooth muscle cell proliferation.
Clinical trials to prevent restenosis after percutaneous coronary revascularization. Ann NY Acad Sci, 1997;811:255. Ip JH, Fuster V, Badimon L, et al. Syndromes of accelerated atherosclerosis: role of vascular injury and SMC proliferation. J Am Coli Cardiol, 1990;1:1667. Libby P, Swanson S, Tanaka H, et al. Immunopathology of coronary arteriosclerosis in transplanted hearts. J Heart Lung Tran~plantation, 1992;11:55. Clausell N, and Rabinovitch M. Upregulation oftibronectin synthesis by interleukin-lp in coronary artery smooth muscle cells is associated with the development of the post cardiac transplant arteriopathy in piglets.
Am J Cardiol, 1995;75:772. Mintz GS, Popma JJ, Hong MK, et al. IVlJS to discern device-specific effects and mechanisms of restenosis. Am J Cardiol, 1996;78(SuppI3A):18. DeVrey E, Mintz GS, Kimum T, et al. Arterial remodelling after DCA: a volumetric Malysis from the Serial Ultrasound Restenosis (SURE) trial [abstract]. J Am Coli Cardiol, 1997;29(Suppl):280A Weiss RH, and Maduri M. The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor. J Bioi Chern, 1993;268(8):5724.
Applications of Antisense Therapies to Restenosis by Alan D. Simon M.D., Mark K. Warshofsky M.D. (auth.), LeRoy E. Rabbani M.D. (eds.)
- Financial Innovations and the Welfare of Nations: How by Laurent L. Jacque (auth.), Laurent L. Jacque, Paul M. Vaaler PDF
- Download e-book for iPad: The Comical: A Philosophical Analysis by Bohdan Dziemidok (auth.)